Financial Year |
March 31 2023 |
Monetary Funds |
745,536,835.63 |
Held-for-trading Financial Assets |
980,000.00 |
Notes Receivable |
98,533,832.95 |
Accounts Receivable |
1,729,141,916.92 |
Advances to Suppliers |
307,886,252.47 |
Other Receivables |
53,350,031.02 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
1,493,242,314.01 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
154,932.00 |
Other Current Assets |
385,087,329.42 |
Total Current Assets |
5,626,391,176.01 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
5,878,315.82 |
Long-term Equity Investment |
41,411,570.42 |
Investment Properties |
-- |
Fixed Assetes |
3,623,792,151.30 |
Under-construction Projects |
2,094,308,413.90 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
696,588,844.13 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
23,352,026.75 |
Deferred Income Tax Assets |
89,497,281.57 |
Other Non-Current Assets |
192,630,892.41 |
Sub-Total of Non-Current Assets |
6,806,529,646.23 |
Total Assets |
12,432,920,822.24 |
Short-Term Loans |
210,241,541.61 |
Trading Financial liabilities |
-- |
Notes Payable |
644,590,821.69 |
Accounts Payable |
684,094,467.25 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
51,501,515.31 |
Taxes Payable |
40,554,985.59 |
Interest Payable |
-- |
Dividend Payable |
9,837,572.17 |
Other payables |
196,719,704.04 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
358,446,610.56 |
Other Current Liabilities |
13,729,779.31 |
Sub-Total of Current Liabilities |
2,311,157,214.43 |
Long-term Loans |
601,761,151.53 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
300,500,000.00 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
77,285,748.21 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
1,245,265,299.93 |
Total Liabilities |
3,556,422,514.36 |
Paid-In Capital(Or Share Stock) |
782,876,800.00 |
Capital Surplus |
2,666,642,131.99 |
Surplus Reserve |
349,014,639.01 |
LESS:Treasury Stock |
89,100,000.00 |
Undistributed Profits |
4,883,810,739.40 |
Minority Stockholder's Interest |
261,807,529.83 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,614,690,778.05 |
Owner's Equity(Stockholder's Equity) |
8,876,498,307.88 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
12,432,920,822.24 |